Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray

Clinical trial NCT05437029 · UNKNOWN

Trial details

NCT number: NCT05437029
Sponsor: Kenneth Palmer
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Prevention

Start date: 2022-06-15
Primary completion: 2022-10-15
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.